Farallon Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Farallon Capital Management’s Portfolio RARE Stock Details RARE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$211K	Sell
2025 Q2	$32.7M	Buy
2024 Q4	–	Sell
2024 Q3	$222K	Sell
2024 Q2	$4.07M	Hold
2024 Q1	$4.62M	Buy